Product NDC: | 50242-090 |
Proprietary Name: | ZELBORAF |
Non Proprietary Name: | Vemurafenib |
Active Ingredient(s): | 240 mg/1 & nbsp; Vemurafenib |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50242-090 |
Labeler Name: | Genentech, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202429 |
Marketing Category: | NDA |
Start Marketing Date: | 20110817 |
Package NDC: | 50242-090-01 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (50242-090-01) > 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
NDC Code | 50242-090-01 |
Proprietary Name | ZELBORAF |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (50242-090-01) > 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC |
Product NDC | 50242-090 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Vemurafenib |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110817 |
Marketing Category Name | NDA |
Labeler Name | Genentech, Inc. |
Substance Name | VEMURAFENIB |
Strength Number | 240 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |